Clinical Trial Update: Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating Nab-Paclitaxel or Paclitaxel with Carboplatin and RTX followed by consolidation in favorable prognosis inoperable Stage IIIA/B non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)
• RTX (RTX)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-05